ETFs With Vertex Pharmaceuticals (VRTX) Exposure
The following ETFs maintain significant exposure to Vertex Pharmaceuticals (VRTX); each of the following funds counts VRTX among its top ten individual holdings. Note that percentages in the table reflect weightings at the beginning of the current month, and are subject to change.
To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.
|Ticker||ETF||ETFdb Category||Expense Ratio||Weighting|
|FBT||NYSE Arca Biotechnology Index Fund||Health & Biotech Equities||0.60%||5.45%|
|IBB||Nasdaq Biotechnology||Health & Biotech Equities||0.48%||4.97%|
|BBH||Market Vectors Biotech ETF||Health & Biotech Equities||0.35%||4.69%|
|XBI||SPDR S&P Biotech ETF||Health & Biotech Equities||0.35%||3.16%|
|GSRA||ALPS/GS Risk-Adjusted Return U.S. Large Cap Index ETF||Large Cap Blend Equities||0.55%||2.51%|
|IJK||S&P MidCap 400 Growth Index Fund||Mid Cap Growth Equities||0.25%||2.45%|
|MDYG||SPDR S&P 400 Mid Cap Growth ETF||Mid Cap Growth Equities||0.25%||2.44%|
|RFG||S&P Midcap 400 Pure Growth||Mid Cap Growth Equities||0.35%||2.30%|
|IVOG||S&P Mid-Cap 400 Growth ETF||Mid Cap Growth Equities||0.20%||1.47%|
|QQQE||NASDAQ-100 Equal Weighted Index Shares||Large Cap Growth Equities||0.35%||1.42%|
|JKH||Morningstar Mid Growth Index Fund||Mid Cap Growth Equities||0.30%||1.41%|
|IJH||Core S&P Mid-Cap ETF||Mid Cap Blend Equities||0.15%||1.24%|
|MDY||SPDR MidCap Trust Series I||Mid Cap Blend Equities||0.25%||0.89%|
|IVOO||S&P Mid-Cap 400 ETF||Mid Cap Blend Equities||0.16%||0.76%|
© 2013 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.